Identification of novel pancreatic lipase inhibitors using structure based virtual screening, docking and simulations studies.
CONCLUSION: Thus, we anticipate that results could be future therapeutic agents and may present an idea toward the experimental studies against the inhibition of pancreatic lipase.
PMID: 30484411 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Gallstones | Gastroenterology | Heart | Hypertension | International Medicine & Public Health | Liver | Liver Disease | Obesity | Pancreas | Stroke | Study | Urology & Nephrology